Related Experiment Video
Updated: Aug 10, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Bank One's worksite-based asthma disease management program
W N Burton1, C M Connerty, A B Schultz
1Bank One, 1 Bank One Plaza, Mail Code: IL1-0006, Chicago, IL 60670-0006, USA. wayne_n_burtonmd@bankone.com
Insights
A workplace asthma program improved employee health and medication adherence. This study shows that worksite interventions can effectively manage asthma, reducing symptoms and promoting proper medication use for better productivity.
Area of Science:
- Occupational Health
- Pulmonary Medicine
- Health Services Research
Background:
- Non-occupational asthma affects 6% of the US population, leading to significant workdays lost and reduced productivity.
- Asthma disease management programs are common in healthcare but rarely implemented in the workplace.
- Worksite interventions are needed to address the impact of asthma on employee health and productivity.
Purpose of the Study:
- To evaluate the effectiveness of a worksite-based asthma disease management program.
- To assess changes in asthma symptom control and medication adherence among employees.
- To determine the potential impact on healthcare costs and worker productivity.
Main Methods:
- A worksite asthma disease management program was implemented.
- A cohort of 76 employees with asthma participated.
- The Asthma Therapy Assessment Questionnaire (ATAQ) was administered at baseline, 2, 4, and 12 months to 41 participants.
Main Results:
- The total ATAQ Index significantly decreased from 3.59 at baseline to 2.76 at 12 months (p < 0.01).
- Participants showed a significant increase in the use of controller medications over reliever medications post-program.
- Improvements suggest better asthma control and adherence to prescribed treatment regimens.
Conclusions:
- A worksite-based asthma disease management program is effective in improving asthma control.
- Such programs can lead to appropriate medication use, potentially reducing absenteeism and healthcare costs.
- Implementing asthma management at the workplace can enhance employee productivity and well-being.
Abstract:
Non-occupational asthma is a common disease affecting approximately 6% of the US population. Asthma accounts for an estimated 3 million workdays lost each year in the United States and for reduced employee job productivity. Although asthma disease management programs are relatively common in managed care organizations, they generally have not been offered at the workplace. A total of 168 employees with asthma were identified, and 76 participated in a worksite asthma disease management program. Of them, 41 (53.9%) completed an Asthma Therapy Assessment Questionnaire (ATAQ) at baseline, post-program (2 months), 4 months, and 12 months. The total ATAQ Index declined from 3.59 at baseline to 2.76 at 12 months (p < 0.01). After the program, significantly more employees reported using controller medications (the desired behavior) rather than reliever medications. A worksite-based disease management program for asthma should reduce medical care costs and absenteeism and improve worker productivity.
More Related Videos
12:22Mindfulness in Motion (MIM): An Onsite Mindfulness Based Intervention (MBI) for Chronically High Stress Work Environments to Increase Resiliency and Work Engagement
Published on: July 1, 2015
07:10Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
Published on: May 20, 2019
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Inhaled Medications
Asthma III: Clinical Manifestations